Atrial fibrillation following aortic valve replacement: impact of perioperative use of intravenous β-blocker

Yokota, Junki; Nishi, Hiroyuki; Sekiya, Naosumi; Yamada, Mitsutomo; Takahashi, Tetsuya

doi:10.1007/s11748-016-0738-9

Cited by 11 publications

(9 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The optimal strategy seems to initiate oral beta-blocker pre-operatively and start landiolol intra-operatively or in the ICU. One retrospective study 44 showed that preoperative oral beta-blockade associated with landiolol is superior to landiolol started alone post-operatively. On the other hand, transition to oral beta-blocker may be necessary if landiolol infusion is stopped early, with patient discharged from ICU.…”

Section: Discussion and Perspectivesmentioning

confidence: 99%

Landiolol for managing atrial fibrillation in post-cardiac surgery

Heringlake

Knotzer

Fornier

et al. 2018

European Heart Journal Supplements

View full text Add to dashboard Cite

show abstract

Section: Discussion and Perspectivesmentioning

confidence: 99%

Landiolol for managing atrial fibrillation in post-cardiac surgery

Heringlake

Knotzer

Fornier

et al. 2018

European Heart Journal Supplements

View full text Add to dashboard Cite

show abstract

“…Tieto výsledky korelujú s prácou autorov Yokota a spol., ktorí prezentujú, že čas CPB, LVEF ani COPD nie sú rizikovými faktormi vzniku POAF. 13 Kohno a spol. taktiež nenašli žiadnu koreláciu medzi celkovým časom chirurgického výkonu, časom CPB alebo časom svorky aorty a vznikom POAF počas AVR.…”

Section: Diskusiaunclassified

“…13 Literárne údaje uvádzajú pooperačnú ap-likáciu-blokátorov ako protektívny faktor vzniku POAF, pričom vynechanie dlhodobej aplikácie -blokátorov na druhej strane riziko vzniku POAF zvyšuje. 8,13 Aj Yokota a spol. uvádzajú pooperačnú aplikáciu -blokátorov ako protektívny faktor vzniku POAF.…”

Section: Diskusiaunclassified

“…uvádzajú pooperačnú aplikáciu -blokátorov ako protektívny faktor vzniku POAF. 13 V našej štúdii je anamnéza užívania -blokátorov rizikovým faktorom vzniku pooperačnej AF (p < 0,01). Z výsledkov vyplýva, že aj krátkodobá absencia užívania -blokátorov v deň operácie a krátko pooperačne môže spôsobiť zvýšenie rizika vzniku POAF.…”

Section: Diskusiaunclassified

See 1 more Smart Citation

(The effect of cardiac venting technique for aortic valve replacement surgery on the incidence of postoperative atrial fibrillation)

Toporcer¹,

Kraus²,

Grendel³

et al. 2019

Cor Vasa

View full text Add to dashboard Cite

Fibrilácia predsiení (AF) je najčastejšou komplikáciou po operácii srdca. Len niekoľko štúdií popisuje incidenciu a rizikové faktory pooperačnej fi brilácie predsiení (POAF) po izolovanej operácii aortálnej chlopne (AVR). Dôležité je aj to, že miesto zavedenia ventu počas AVR môže vytvoriť lokality s pomalým vedením vzruchu, čo predstavuje substrát pre vznik re-entry. Cieľom štúdie je porovnať vplyv techniky zavedenia ventu cez truncus pulmonalis (PA) a pulmonálnu žilu (PV) počas AVR na incidenciu POAF. Do retrospektívnej štúdie boli zaradení pacienti (n = 497) podstupujúci izolovanú AVR, okrem pacientov s predoperačnou permanentnou AF alebo implantovaným kardiostimulátorom. Použitie techniky ventovania srdca cez PV v porovnaní s ventom cez PA je spojené so signifi kantnou prolongáciou času mimotelového obehu o 10,6 minúty (p < 0,0001, 95 % CI 7,76-13,35), času svorky aorty o 7,7 minúty (p < 0,0001, 95% CI 5,34-10,16), predĺžením pobytu pacienta na jednotke intenzívnej starostlivosti o jeden deň (p = 0,0025, 95% CI 0,34-1,56) a času hospitalizácie o 1,4 dňa (p = 0,003, 95% CI 0,34-2,23). Skupina pacientov s ventom zavedeným cez PV vykazovala v porovnaní s pacientmi s ventom cez PA 32%-ný relatívny nárast incidencie POAF (34 %-PA, 45 %-PV, p = 0,03). Univariačná logistická regresná analýza identifi kovala implantáciu ventu cez PV ako rizikový faktor vzniku POAF (p = 0,04, OR 1,50, 95% CI 1,02-2,22).

show abstract

“…Studies showed that POAF could lead to a longer hospital stay and a greater incidence of other complications [2]. POAF risk is higher among patients who are older [3], racial/ethnic minorities [4], taking perioperative medications such as β-blocker [5], and having hypertension [6] or operative trauma [7].…”

Section: Introductionmentioning

confidence: 99%

The role of surgery type in postoperative atrial fibrillation and in-hospital mortality in esophageal cancer patients with preserved left ventricular ejection fraction

et al. 2020

View full text Add to dashboard Cite

Background Postoperative atrial fibrillation (POAF) is one of the most common complications of esophagectomy, which may extend the inpatient hospital stay. Minimally invasive esophagectomy (MIE) has been increasingly used in clinical practice; however, its POAF risk and short-term mortality remain unclear. This study aimed to examine the POAF risk and in-hospital mortality rate between patients receiving MIE and open esophagectomy (OE). Methods Esophageal cancer patients who underwent MIE or OE from a retrospective cohort study were evaluated. A multivariate logistic regression model was built to assess the associations between esophagectomy (MIE vs. OE) and various outcomes (POAF, in-hospital mortality). Covariates included age, sex, body mass index, neoadjuvant therapy, tumor stage, surgery incision type, comorbidities, cardia conditions, peri-operative medication, and complications. Results Of the 484 patients with esophageal cancer, 63 received MIE. A total of 53 patients developed POAF. Compared to patients receiving OE, MIE patients had 81% reduced odds of POAF (adjusted odds ratio [aOR] 0.185, 95% CI 0.039–0.887, P = 0.035). No statistically significant association was found for in-hospital mortality (aOR 0.709, 95% CI 0.114–4.409, P = 0.712). Conclusions MIE is associated with a lower risk of POAF, compared to traditional surgery. No significant short-term survival benefit was found for MIE.

show abstract

Atrial fibrillation following aortic valve replacement: impact of perioperative use of intravenous β-blocker

Cited by 11 publications

References 20 publications

Landiolol for managing atrial fibrillation in post-cardiac surgery

Landiolol for managing atrial fibrillation in post-cardiac surgery

(The effect of cardiac venting technique for aortic valve replacement surgery on the incidence of postoperative atrial fibrillation)

The role of surgery type in postoperative atrial fibrillation and in-hospital mortality in esophageal cancer patients with preserved left ventricular ejection fraction

Contact Info

Product

Resources

About